GESTIÓN EN SALUD PÚBLICA: CDRH Biothreat Challenge – precisionFDA: Join the challenge to identify biothreat pathogens

miércoles, 15 de agosto de 2018

CDRH Biothreat Challenge – precisionFDA: Join the challenge to identify biothreat pathogens

CDRH Biothreat Challenge – precisionFDA

U.S. Food and Drug Administration - Medical Countermeasures Initiative Update

Join the challenge to identify biothreat pathogens

Professional and citizen scientists: test your bioinformatics skills and software tools

Professional and citizen scientists are invited to test their bioinformatics skills and software tools in a challenge to identify pathogens from the FDA-ARGOS database within host samples using NGS short-read data.

Many infectious diseases have similar signs and symptoms, making it challenging for healthcare providers to identify the disease-causing agent. Infectious disease next-generation sequencing (ID-NGS) technology may enable the diagnosis of infections without prior knowledge of the disease's cause.

To encourage the development and improvement of ID-NGS analytical methods, precisionFDA – the community platform for NGS assay evaluation and regulatory science exploration – is launching the precisionFDA CDRH Infectious Disease NGS Diagnostics Biothreat Challenge.

Professional and citizen scientists are invited to test their bioinformatics skills and software tools in a challenge to identify pathogens from the FDA-ARGOS database within host samples using NGS short-read data. This challenge will enable the community to look at algorithm performance using a fixed reference genome standard.

The challenge is open now through October 4, 2018.